While digital clinical trials provide more opportunity, they also present unique challenges that can significantly impact the trial results.
Jiang Li
Advertisement
Jiang Li is CEO of Vivalink.
Articles by Jiang Li
Jiang Li, CEO of Vivalink, continues his conversation with Pharmaceutical Executive, this time discussing the impact of continuous monitoring on patient adherence.
Vivalink’s CEO Jiang Li, PhD, discusses the importance of including as much information with clinical data as possible.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
2
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
3
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5